FDA Approves MDMA for Clinical Trial Use Investigating Schizophrenia
Ben Sessa
Sat, Jun 10
The study will assess the use of the drug to treat impaired social motivation, or asociality, which is a difficult-to-treat symptom of schizophrenia that can cause significant functional impairment.
Discover